Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.
Related Posts
Carmakers Highlight U.S. Manufacturing in Bid to Influence Trump Over Tariffs
Wary of directly criticizing the president’s trade policies, automakers are emphasizing how much they have already invested in U.S. manufacturing.
Yale’s Endowment Selling Private Equity Stakes as Trump Targets Ivies
The university is selling multiple stakes in private-equity funds as the industry struggles and Trump targets Ivy-League Institutions.
Stocks Rebound After S&P’s Fall Into Correction, but Trump Tariffs Keep Markets on Edge
The gains on Friday were the biggest daily jump since President Trump’s election. But they weren’t enough to overcome steep tariff-induced losses earlier in the […]